RENOWNED/PREVIOUS SPEAKERS

Tracks & Key Topics

Academic Key Topics

Business Key Topics

About Conference

International Conference on World Cardiology welcomes you for the 25th Edition this time in Zurich, Switzerland scheduled on April 12-13, 2021.

Cardiology 2021 Conferences will be an examination of the newest successions in heart disease recovery and prevention and on new analysis of innovation within the field of cardiac specialty. Cardiology Conferences will lay a platform for scientists, world-class professors, and Cardiologists to discuss an approach for Cardiovascular Diseases. International Cardiology Conferences is designed to provide diverse and current education that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and vascular devices have been developed which helped for the treatment of cardiac disorders, replacement and repair therapy. Robotic surgeries for the cardiac and vascular surgery which has been favorable in a wide range.

Cardiac symposiums are rejuvenating. It is inspirational and energizing opportunity to connect with the greater scientific community, where you get to know about new cardiac strategies to approach your research. To contemplate the bigger picture and establish collaborations. A good conference has the capacity to bring a scientist within you; Cardiology conferences are very helpful for learning about new areas and publications of cardiology.

Cardiology Conferences 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Target Audience:

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetings, Interactive Sessions, Panel Discussions, Keynote Sessions, Poster Presentations, Oral Presentations, Workshops, Exhibitions etc., are the main highlights of this event.

Benefits of PHYSICAL EVENT:

Benefits of ONLINE EVENT/WEBINARS:

Scope & Importance:

Cardiology 2021 and Cardiovascular Conferences will seam world-class educators, scientists and cardiologists to converse diverse procedures for heart disorder remediation, Electrocardiography, Heart Failure, Nuclear Cardiology.

Cardiology Conferences, Cardiology Meetings are envisioned to deliver flexible information that will keep cooperative experts next to each other of the topics impacting the anticipation, discovery and treatment of cardiovascular infection. The world is becoming gradually exposed to public health challenges and risks for heart diseases. This conference provides a unique prospect for academicians, educators & clinicians as well as for experts and scholars of higher education from all across the globe to convey and share unique ideas on crucial matters and latest trends in the field of cardiology. Starting from prevention through optimal care and finally the targeted treatment modes & rehabilitation, the whole range of cardiovascular disease shall be presented with world-class faculty, researchers, and mentors as well as healthcare clinical professionals.

Overview of Cardiology 2021:

The Innovative idea of Cardiology has started a great many research to be embraced by the labs around the world. Cardiology at Zurich will manage Cardiac Prevention, Diagnosis, and Treatment of illnesses and its inventive strategies. Cardiology 2021 will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Heart diseases and in addition to check out the new thoughts and ideas on worldwide scale and the themes include Clinical Cardiology, Hypertension, Vascular Biology, Cardiovascular Diseases And Heart, Interventional Cardiology, Cardiac Nursing, Cardiac Surgery And Transplantation, Cardio-Oncology, COVID-19 Challenges: Cardiology, Cardiovascular Toxicology And Pharmacology, Women Cardiology, Pediatric Cardiology, Molecular Cardiology, Electrocardiography, Cardiology: Lifestyle & Nutrition, Diabetes & Heart, Cardiac Diagnostic Tests, Cardiac Regeneration, Advances In Cardiovascular Imaging, Latest Approaches In Cardiovascular Surgery, Cardiac Rhythm Abnormalities, Heart Disease: Complications, Cardiology: Complementary & Alternative Treatments, Clinical Case Reports On Cardiology, Current Research In Cardiology.

Main Sessions

Track 1: Hypertension

High blood pressure or hypertension increases the risk of heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol, smoking, and family history. Beta-blockers are a common treatment for hypertension. High blood pressure usually does not cause symptoms. Long term high blood pressure is a main risk factor for coronary artery disease, stroke, heartfailure, peripheral vascular disease, vision loss, and chronic kidney disease.

Track 2: Cardiovascular diseases and Heart

Heart attacks and strokes are usually acute events and are mainly caused by a blockage that prevents blood from flowing to the heart or brain. The most common reason for this is a build-up of fatty deposits on the inner walls of the blood vessels that supply the heart or brain. Strokes can also be caused by bleeding from a blood vessel in the brain or from blood clots. The cause of heart attacks and strokes are usually the presence of a combination of risk factors, such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol, hypertension, diabetes and hyperlipidemia.

Track 3: Interventional Cardiology

Interventional cardiology is a branch of cardiology that deals specifically with the catheter-based treatment of structural heart diseases. Interventional cardiology is a non-surgical option which uses a catheter – a small, flexible tube – to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure. A large number of procedures can be performed on the heart by catheterization. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery. Additionally, interventional cardiology procedure of primary angioplasty is now the gold standard of care for an acute myocardial infarction.

Track 4: Cardiovascular toxicology and Pharmacology

Cardiovascular toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Cardiovascular pharmacology manages the drug of heart illnesses. Cardiac drugs are utilized to treat states of the heart or the circulatory or vascular framework. Many classes of cardiovascular operators are accessible to treat the different cardiovascular conditions. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

Track 5: Cardiac surgery and Transplantation

Coronary artery bypass grafting (CABG) is the most usual type of heart surgery. CABG boosts blood flow to the heart. Surgeons make use of CABG to treat people who have critical Coronary Heart Disease (CHD). For the heart to work well, blood should flow in only one direction. The heart's valves help to make this possible. Healthy valves open and close in a specific way as the heart pumps blood. Each valve has one set of flaps called leaflets. The leaflets open to allow blood to pass from one heart apartment into another or into the arteries. Then the leaflets close tightly to cease blood from flowing backward. Heart surgery is applied to fix leaflets that do not open as wide as they should. This can happen if they become thick or stiff or join. As a result, not enough blood flows through the valve. This Heart Congress scientific program has been CME and CPD certified.

Track 6: Structural heart disease interventions

Structural heart diseases are structural defects in the heart which may be present from the initial stages of birth, which need to be rectified by surgical interventions. Transcatheter techniques applied for treating non-coronary heart diseases are known as structural heart interventions. New opportunities continue to unfold in the field of treating structural heart interventions. The Present day structural heart intervention training programs include both valvular and non-valvular techniques concentrating on a wide range of adult primary congenital heart defects and complex surgical residual defects infant population. Many cardiologists prefer a new branch of percutaneous treatment which targets congenital and acquired diseases that were not addressed or were treated in another complex manner. Percutaneous structural heart interventions require a multi-axle approach involving cardiac imaging specialists, clinical cardiologists, interventional cardiologists, pediatricians and expert cardiac surgeons. A thorough assessment on patient procure compatibility must be made. Continuous enhancement of knowledge and training in materials and devices to be used individual specific procedures is a prerequisite. The catheterization lab in the hospital must be equipped to perform hybrid procedures.The following structural conditions are grouped together.

Track 7: Heart disease in women

Heart disease is a killer that strikes women than men and is more deadly. Women of all ages can be affected with heart disease. For younger women, the combination of smoking boosts and birth control pills, heart disease risks by 20 percent. In women risk increases with age, certain things like sedentary lifestyle and overeating can cause accumulation of plaque which leads to clogged arteries later.

Track 8: Current research in Cardiology

Track 9: Complications of Heart disease

Track 10: Cardiovascular Pharmacology

Pharmacology of vascular endothelium deals with modifications of endothelial cells and the vasculature play a crucial part in the pathogenesis of a wide range of the most dreadful of human diseases, as endothelial cells have the vital role of participating in the maintenance of patent and functional capillaries.

Track 11: Cardiology - future medicine

Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients’ expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modelling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Accessible 'at-a-glance' formats are important in an increasingly time-constrained clinical community. Topics include the following areas:

Track 12: Clinical Cardiology

This session plays a significant role in the future of cardiology research. Cardiology concerns with diseases and disorders of the heart, such as coronary artery disease and congestive heart failure. The clinical cardiology includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, vascular heart disease and electrophysiology.

Track 13: Clinical case reports on cardiology

Cardiology case reports give an appropriate assemblage for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are reinforced. Furthermore, studying diagnostic methods from medical cases and interpretation of symptoms is significant to train and increase the processes which are being used in the clinical field.

Track 14: Diabetes & Heart

The term "Diabetic Heart Disease" (DHD) means heart disease that occurs in people who have high content of carbohydrate in blood. In comparison with people who don't have diabetes, people who have diabetes; are at a higher risk of heart disease, have additional reasons of heart disease, may develop heart disease at a younger age, may have more severe heart diseases. In Congenital Heart Disease, a waxy substance called plaque builds up inside the coronary arteries. These arteries supply our heart muscle with blood rich in oxygen. Plaque constitutes of fat, cholesterol, calcium, and various other substances found in the blood. When plaque happens in the arteries, the condition is called atherosclerosis. This Heart Congress scientific program has been CME and CPD certified.

Track 15: New directions in Cardiovascular surgery

The future holds dramatic advances that will transform the cardiac surgeon, in part, into an intervention list with new skills in diagnostic and therapeutic approaches to structural heart disease. The cardiovascular surgery has achieved great progress both on scale and technology though development over the past thirty years. However, the technical predominance of cardiovascular surgery in therapies for some diseases has been weakened, along with developments of new drugs and interventional technology. Currently, cardiovascular surgeons should practice the "patient first" principle, carry out individual customized treatment and precision therapy, absorb the advantages of other subjects like intervention and imaging in order to achieve technological breakthroughs, create new treatment technologies and models with smaller trauma and better outcome, establish heart team to provide patient oriented treatment. Besides, cardiovascular surgeons should improve knowledge system by learning related technology and science, become hybrid Doctor of Research. Cardiovascular surgeons should pay high attention to critical effect of research on the disciplinary development, change the medical practice by virtue of research achievements, direct the treatment for cardiovascular diseases, and finally provide better health service and rebuild the predominance of cardiovascular surgery.

Track 16: Electrocardiography

Electrocardiography (ECG) is the method of recordance of the electrical activity of the heart over a time period using electrodes placed on the skin. These electrodes help in the detection of the minute electrical changes on the skin that arise from the electrophysiologic pattern of heart muscle while depolarizing during each heartbeat. This record called the electrocardiogram (also known as an ECG), gives information about the part of the heart that triggers each heartbeat (the pacemaker called the Sino-atrial node), the nerve conduction pathways of the heart, and the heart rate and rhythm . Usually, an ECG is obtained if a heart disorder is suspected. This Heart Congress scientific program has been CME and CPD certified.

Track 17: Cardiac and Cardiovascular research

Cardiovascular research is to learn the basic, translational, and clinical research of cardiovascular diseases. Cardiovascular diseases, including Heart Rhythm and Arrhythmias, HIV and Heart Disease, Imaging, Interventional Cardiology, Myocardial Biology/Heart Failure, Preventive Cardiology, Women and Heart Disease, congestive heart failure, hypertension, atherosclerosis, stroke, aneurysms, and vascular auto-immune diseases are the most common cause of death and disability in the United States, and account for approximately 30% of deaths and health care costs annually in this country and developed societies. The mission of Cardiovascular Research is to support interdisciplinary research in basic, translational and clinical cardiovascular sciences, including cardiovascular development, function, pathophysiology, pharmacology, genetics, genomics, and proteomics, and to apply this knowledge to better understand the causes of cardiovascular diseases and to pioneer development of new innovative therapies and approaches to prevent or treat them.

Track 18: Advances in Cardiovascular imaging

Advanced Cardiac imaging, using cardiac magnetic resonance imaging (MRI) and multi detector computed tomography (CT), is increasingly used in the work-up of athletes with suspected abnormalities on screening. Both imaging modalities produce highly accurate and reproducible structural and functional cardiac information. Cardiac MRI has the advantage of imaging without radiation exposure or the use of iodine-containing contrast agents but is sometimes not possible due to claustrophobia or other contraindications. Although cardiac MRI can rule out coronary artery anomalies, multi detector CT is superior to cardiac MRI for visualizing the full extent of the coronary arteries and atherosclerotic coronary artery disease. Echocardiography remains the most advanced tool for noninvasive cardiac imaging because of its applicability for most cardiac disorders and its exquisite spatial resolution.

Track 19: Vascular Biology

The Vascular Biology exists as a wide-ranging discipline that includes study of vascular function, structure, growth as well as development. This field comprises investigation at essentially all levels, including studies of molecules, cells, organs also intact organisms. Perturbations of vascular function be there involved in various pathophysiological states, with neoplasia, inflammation, aging, neurological diseases, metabolic disorders pulmonary diseases also hypertension.

Track 20: Cardiac diagnosis test

The diagnostic tests are used for identifying the heart function & heart conditions associated with healthy vs. unhealthy individuals in cardiology. Cardiac stress testing is used to assess the cardiac function and to disclose the evidence of cardiac hypoxia. In the areas of perfusion abnormalities, thallium 0r technetium can be used through Radionuclide test. With a maximal stress test, the level of exercise gets increases until the person's heart rate will not increase highly. Coronary catheterization, echocardiogram, intravascular ultrasound, and the coronary calcium scan are given as the cardiac imaging techniques which can be used in cardiac diagnosis.

Market Analysis

Cardiology 2021 is a two-day conference which is going to be conducted as physical event on April 12-13, 2021 in Zurich, Switzerland. This will be a great platform to gather and share knowledge, presentations, panel discussions, interactive dialogue about the developing world of cardiology. This conference brings together the researchers, scientists, professors, students, cardiologists who dispense an international forum on extending of approved research.

Cardiology is a branch of medicine dealing with disorders of the heart be it human or animal. This subject is associated with medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Doctors who specialize and practice in this field are called cardiologists, a specialty of internal medicine.

Greatest Achievements in the Field of Cardiology:

The United States is a huge market for Cardiology Surgical & Interventional Cardiology devices due to factors like high healthcare expenditures, awareness levels, and sophisticated healthcare infrastructure. The market is expected to show a huge growth owing to the presence of high unfilled medical needs mainly coming from China and Japan. The increasing widespread presence of cardiovascular diseases is the leading factor driving the market. The World Heart Federation (WHF) unites 200 members bridging 100 countries in the fight against cardiovascular disease, Global Data research predicts the worldwide market for CMD devices will reach $1.6 billion by 2021.

Rapidly growing fractions within interventional cardiology are expected to be led by new technologies, such as CTO crossers, FFR guide wires, and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices.

Just like other medical device markets, the interventional cardiology market has been witnessing consolidation in recent years. Through strategic mergers and acquisitions, large competitors are either entering the overall market or expanding their reach by entering new segments.

Bundling of devices at a discount has become risen trend because of consolidation. Bundling is driven by unfavorable reimbursement conditions and larger competitors who have a wide variety of devices to offer across the interventional cardiology market and can negotiate more cost-effective contracts with hospitals and labs. As a result, competitive pressure is expected to contribute to declines in prices across most of the segments in the market around the globe.

The Asia Pacific interventional cardiology devices market is habituated to be a bystander to significant gains, at a CAGR of over 9.0% from 2014 to 2020 due to the increasing popularity of cardiovascular disorders in geriatric and pediatric population, growing awareness about the cost efficacy and efficiency provided by these devices and rising health care expenditure levels.

Interventional Cardiology Market Share Insights:

Both the US and European Interventional Cardiology Markets are largest for the coronary stent, coronary balloon catheter, coronary embolic protection device, and coronary thrombectomy device markets.

In the United States, Interventional Cardiology procedures are broken into four segments: angiography procedures, angioplasty/PCI procedures, coronary atherectomy procedures, and catheterization procedures. Of these, the amount of catheterization procedures performed annually in the US is the largest, at just under four million.

The European market has these same four segments and an embolic protection device procedure segment. The number of catheterization procedures are also the largest in Europe, at over five million annually.

Many companies enjoy strong positions in the interventional cardiology device market. US-headquartered Boston Scientific is the largest firm accounting for 23.3% of world consumption over a total annual sale of $2.8 billion. With an estimated 21.8% of the total market share the second position is held by Abbott Laboratories, not far behind are the Dublin-based Medtronic with estimated sales of $1.3 billion – a 10.6% market share. However, the market leader for coronary stents is Abbott Laboratories with an estimated 24.4% share in the market. Lastly, St. Jude dominates the vascular closure devices segment with 44.8% of the global revenue.

Medtronic offers a vast selection of devices across many market segments, allowing it to gain a strong position in the competitive landscape. The company is expected to increase its share over the forecast period as it continues to implement this comprehensive strategy.

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

World Cardiology

Theme: COVID-19 Challenges for Cardiology

Event Date & Time

Event Location

20 Years Of Excellence in Scientific Events

- Quick Links -